·Confidence 85%
AI-Designed Drug Shows Promise in Reversing Biological Aging
Key takeaways
- Insilico Medicine's AI-engineered drug rentosertib demonstrates significant biological age reduction in patients, advancing to Phase III trials for IPF
Analysis
Insilico Medicine's AI-engineered drug rentosertib demonstrates significant biological age reduction in patients, advancing to Phase III trials for IPF
0 likes · 0 dislikes